{
    "data": [
        {
            "id": "69a1e118f2604c0001f48bb1",
            "title": "Berkshire Hathaway Q4 Preview: Can Greg Abel Step Out From Warren Buffett&#39;s Long Shadow?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Berkshire Hathaway Inc </strong><a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"BRK-A\" href=\"https://www.benzinga.com/quote/BRK-A\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/BRK\" target=\"_blank\">BRK</a>)<a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"BRK-B\" href=\"https://www.benzinga.com/quote/BRK-B\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/BRK\" target=\"_blank\">BRK</a>)<!-- --> is set to announce fourth-quarter financial results <a href=\"https://www.benzinga.com/trading-ideas/long-ideas/26/02/50667126/next-berkshire-hathaway-letter-comes-soon-and-it-wont-be-from-buffett\" target=\"_blank\">Saturday (Feb. 28)</a>, its first earnings release in decades without legendary investor <strong>Warren Buffett</strong> serving as CEO.</p><!--/$--><!--$--><p class=\"block core-block\">Here's what investors should know about the report and what could be ahead for the company.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Berkshire Q4 Estimates</h2><!--/$--><!--$--><p class=\"block core-block\">Analysts expect the conglomerate to report fourth-quarter revenue of $92.91 billion, down from $94.92 billion a year earlier, <a href=\"https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022726&amp;t=be2bearmibe3na1\" target=\"_blank\">Benzinga Pro data show.</a> The company has beaten revenue estimates in more than four straight quarters.</p><!--/$--><!--$--><p class=\"block core-block\">In the most recently reported <a href=\"https://www.benzinga.com/markets/equities/25/11/48578414/berkshires-big-q3-fueled-by-over-200-underwriting-surge\" target=\"_blank\">third quarter</a>, the company highlighted operating earnings being up 34% year-over-year, thanks to insurance profit gains.</p><!--/$--><!--$--><p class=\"block core-block\">The market will be watching to see if the insurance segment led the way again with strong underwriting profits.</p><!--/$--><!--$--><p class=\"block core-block\">Financial results will be released at 8 a.m. ET Saturday, Feb. 28.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">First Greg Abel Shareholder Letter</h2><!--/$--><!--$--><p class=\"block core-block\">Saturday's report doesn’t just mark quarterly results, but include coverage of the full financial year. This means investors will get treated to Berkshire’s annual shareholder letter.</p><!--/$--><!--$--><p class=\"block core-block\">For years, investors and analysts have looked forward to the annual missive from Buffett, which included thoughts on the overall market, the company's operating segments, quotes on investing and words of wisdom.</p><!--/$--><!--$--><p class=\"block core-block\">New CEO<strong> Greg Abel </strong>takes over with his first letter Saturday, attempting to fill the big shoes of the investing icon.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Investors are eager to hear his plans for the company’s more than $300 billion in idle cash. Will he signal interest in new investments or potential acquisitions? He may also hint at whether Berkshire could break with tradition and finally pay a dividend.</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">He may also offer macro views on key sectors such as financials, oil, insurance, and railroads, given the company’s mix of operating businesses and its large investment portfolio.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Top 10 Holdings</h2><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$?--><template id=\"B:5\"></template><div></div><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$?--><template id=\"B:6\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">The SPDR S&amp;P 500 ETF Trust gained 16.6% in 2025, <a href=\"https://www.benzinga.com/trading-ideas/long-ideas/26/12/49657109/warren-buffett-trails-sp-500-in-final-year-as-berkshire-ceo-heres-his-25-year-scorecard\" target=\"_blank\">outperforming the 11.4% gain</a> of Berkshire Hathaway stock in 2025.</p><!--/$--><!--$--><p class=\"block core-block\">Of the top 10 holdings at the end of the year, only American Express, Bank of America and Alphabet beat the S&amp;P 500. This low number of top 10 holdings likely contributed to Berkshire's overall underperformance versus the S&amp;P 500.</p><!--/$--><!--$--><p class=\"block core-block\">While Abel has already indicated his thoughts on Kraft Heinz, investors will be looking forward to any commentary from the new CEO on the other top holdings.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50939536\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/The-Berkshire-Hathaway-Logo-Appears-On-A.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/previews/26/02/50939536/berkshire-hathaway-q4-preview-greg-abel-warren-buffett",
            "pub_date": "2026-02-28 02:23:24",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1e199f2604c0001f48c03",
            "title": "Rocket Lab Just Doubled Its Business, So Why Is The Stock Tanking?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Rocket Lab Corp. </strong><a href=\"https://www.benzinga.com/quote/RKLB\" rel=\"noreferrer noopener\" target=\"_blank\"></a><a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"RKLB\" href=\"https://www.benzinga.com/quote/RKLB\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/RKLB\" target=\"_blank\">RKLB</a>)<!-- --> shares extended <a href=\"https://www.benzinga.com/trading-ideas/movers/26/02/50924082/why-is-rocket-lab-stock-falling-friday\" target=\"_blank\">their post-earnings decline</a> into Friday, even after topping expectations on both revenue and earnings, as two analysts pointed to the same strong results but drew sharply different conclusions about the stock's near-term trajectory.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em>Rocket Lab stock is among today’s weakest performers. <a href=\"https://www.benzinga.com/quote/RKLB\" rel=\"noreferrer noopener\" target=\"_blank\">Why is RKLB stock dropping?</a></em></strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Both <strong>Citizens JMP Securities </strong>and<strong> Cantor Fitzgerald </strong>cited revenue beats and growing backlogs; their outlooks diverged: Citizens flagged execution and valuation risks, while Cantor highlighted scale and contract momentum as long-term drivers.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Execution Risks Could Temper Upside</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Citizens JMP </strong>analyst <strong>Trevor Walsh</strong> maintained a <strong>Market Perform</strong> <a href=\"https://www.benzinga.com/quote/RKLB/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">rating </a>after Rocket Lab posted fourth-quarter revenue of $179.7 million, up 36% year-over-year and ahead of the $177.2 million consensus, with adjusted EBITDA of ($17.4 million) also topping expectations.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">He lowered his fiscal 2026 non-GAAP earnings per share estimate to a loss of 8 cents from a loss of 6 cents, and cut his fiscal 2027 estimate to 9 cents from 11 cents.</p><!--/$--><!--$--><p class=\"block core-block\">The stock is trading at 30.1 times the calendar 2027 estimated enterprise value-to-revenue, a 343% premium to the aerospace and defense peer group. Walsh said elevated valuation, reliance on government contracts, and execution risk around Neutron could limit near-term multiple expansion.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Growing Contract Pipeline Justifies Higher Stock Price</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Cantor Fitzgerald </strong>analyst <strong>Andres Sheppard</strong> reiterated an <strong>Overweight </strong>rating and raised his price forecast to $85 from $72, pointing to record fiscal 2025 revenue of $601.8 million, 21 successful launches, and a backlog that roughly doubled to ~$1.85 billion from the prior quarter, with ~37% expected to be recognized within 12 months.</p><!--/$--><!--$--><p class=\"block core-block\">Despite the Neutron delay to the fourth quarter of 2026 — after the company said it will \"completely replace the manufacturing process that introduced the defect\" — Sheppard does not expect a material impact on the company's long-term trajectory.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">He raised his fiscal 2026 and fiscal 2027 revenue estimates to $871.4 million and $1.29 billion, respectively, and values the stock using a 10-year discounted cash flow (DCF) model, citing improved scale, higher average selling prices (ASPs), and backlog growth as support for his higher price forecast.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>RKLB Price Action:</strong> Rocket Lab shares were down 9.55% at $65.70 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by Emagnetic via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50939615\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Rocket-Lab-Building-Sign--Auckland--New-_0.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50939615/rocket-lab-just-doubled-its-business-so-why-is-the-stock-tanking",
            "pub_date": "2026-02-28 02:25:33",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1dfadf2604c0001f48b0e",
            "title": "What&#39;s Going On With Rigetti Computing (RGTI) Stock Friday?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Rigetti Computing Inc</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"RGTI\" href=\"https://www.benzinga.com/quote/RGTI\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/RGTI\" target=\"_blank\">RGTI</a>)<!-- --> shares are tumbling on Friday as the company prepares to report its earnings next week, amid a broader sell-off in the tech sector. Here’s what investors <a href=\"https://www.benzinga.com/news/politics/26/02/50932619/producer-inflation-january-market-reactions\" target=\"_blank\">need to know</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Rigetti Computing stock is taking a hit today. <a href=\"https://www.benzinga.com/quote/RGTI\" rel=\"noreferrer noopener\" target=\"_blank\">Why is RGTI stock dropping?</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Rigetti Earnings Due March 4</h2><!--/$--><!--$--><p class=\"block core-block\">Analysts are closely watching Rigetti’s upcoming <a href=\"https://www.benzinga.com/quote/RGTI/earnings\" target=\"_blank\">earnings report</a> scheduled for March 4, with expectations of a loss of 4 cents per share on revenue of $2.46 million. </p><!--/$--><!--$--><p class=\"block core-block\">This follows a previous loss of 8 cents per share and revenue of $2.27 million, indicating a potential improvement in financial performance.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">IonQ Delivers Massive Revenue Beat</h2><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">This performance has raised expectations across the sector, as investors look for similar growth indicators from Rigetti in its upcoming report.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">QBTS Falls After Target Cuts</h2><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">The company posted an adjusted fourth-quarter loss of 9 cents per share on revenue of $2.75 million, missing forecasts, but bookings jumped 471% to $13.4 million and cash and securities reached $884.5 million. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">For 2025, revenue surged 179% to $24.6 million, which CEO <strong>Alan Baratz</strong> <a href=\"https://www.benzinga.com/pressreleases/26/02/b50881758/d-wave-reports-fourth-quarter-and-year-end-2025-results\" target=\"_blank\">called</a> one of the most transformative years in D-Wave's history.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Momentum Cools After Sharp Rally</h2><!--/$--><!--$--><p class=\"block core-block\">Rigetti Computing shares have had a volatile past year, climbing from around $7.50 to a peak near $56.34 in late 2025 before sliding back into the high-teens by February 2026. </p><!--/$--><!--$--><p class=\"block core-block\">Short-term moving averages have rolled over and converged with the price while the 200-day average continues to slope upward, suggesting momentum has cooled sharply even as the longer-term trend remains positive.</p><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">RGTI Shares Slide Friday Afternoon</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>RGTI Price Action:</strong> Rigetti Computing shares were down 9.76% at $16.82 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50939385\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Los-Angeles--California---August-3-2025-.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50939385/whats-going-on-with-rigetti-computing-rgti-stock-friday",
            "pub_date": "2026-02-28 02:17:20",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1dc46f2604c0001f48739",
            "title": "A Preview Of Harrow&#39;s Earnings",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Harrow (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/HROW\" target=\"_blank\">HROW</a>) is preparing to release its quarterly earnings on Monday, 2026-03-02. Here's a brief overview of what investors should keep in mind before the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts expect Harrow to report an <strong>earnings per share</strong> (EPS) of $0.42.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The announcement from Harrow is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings History Snapshot</h3><!--/$--><!--$--><p class=\"block core-block\">During the last quarter, the company reported an EPS beat by $0.11, leading to a 13.47% increase in the share price on the subsequent day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Harrow's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><h3 class=\"block core-block\">Performance of Harrow Shares</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Harrow were trading at $53.99 as of February 26. Over the last 52-week period, shares are up 108.97%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Delving into Harrow's Background</h3><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$--><h3 class=\"block core-block\">Harrow: Delving into Financials</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Positive Revenue Trend:</strong> Examining Harrow's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>45.44%</strong> as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> Harrow's net margin excels beyond industry benchmarks, reaching <strong>1.42%</strong>. This signifies efficient cost management and strong financial health.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>2.11%,</strong> the company showcases effective utilization of equity capital.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> Harrow's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.29%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>5.36</strong>, caution is advised due to increased financial risk.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/HROW/earnings\" target=\"_blank\"><strong>To track all earnings releases for Harrow visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/earnings_preview_3.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50938507/a-preview-of-harrows-earnings",
            "pub_date": "2026-02-28 02:02:50",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1dc81f2604c0001f48772",
            "title": "This Jazz Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href=\"https://www.benzinga.com/analyst-stock-ratings\" target=\"_blank\">analyst ratings page</a>.</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Considering buying JAZZ stock? Here’s what analysts think: </p><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-middle-50938561\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Analysts-Adjust-Progressive-Targets.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/initiation/26/02/50938561/this-jazz-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-friday",
            "pub_date": "2026-02-28 02:03:49",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}